Biogen Stock Surges As FDA Fast-Tracks Alzheimer's Drug Application

Biogen Stock Surges As FDA Fast-Tracks Alzheimer's Drug Application

Biogen stock surged after the firm said the FDA has decided to fast track its application to bring Alzheimer's disease drug aducanumab to market.